Sohini Das
 "Sohini Das")
Sohini Das
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Page 46 - Sohini Das
Sanofi consumer brands get a shot in the arm on demerger decision
Sanofi Consumer Healthcare India is expected to be listed on both the BSE and NSE, the company said in an exchange notification
 "Sanofi consumer brands get a shot in the arm on demerger decision")
Lupin reports 12% rise in Q4 sales riding on API, US and India biz
The revenue growth came from a strong API business performance along with US and domestic market sales growth
 "Lupin reports 12% rise in Q4 sales riding on API, US and India biz")
Govt, industry meet to focus on trade margin rationalisation of drugs
The Centre has been mulling on rationalizing drug trade margins for a while now for widely used medicines in an effort to bring down prices
 "Govt, industry meet to focus on trade margin rationalisation of drugs")
Drug sales stuck at pre-pandemic level, price rise shapes market growth
Respiratory medicines doing well as people recover from long-term effects of Covid-19
 "Drug sales stuck at pre-pandemic level, price rise shapes market growth")
Likely $10-billion injection: India's medtech a picture of health
Centre notifies the National Medical Devices Policy, 2023
 "Likely $10-billion injection: India's medtech a picture of health")
India's contribution to global clinical trials at 4% during 2010-22: Study
Top 20 pharma-sponsored trials in the country has increased by 10 per cent since 2013
 "India's contribution to global clinical trials at 4% during 2010-22: Study")
Luxury car maker Audi India starts production of Q3 SUV at Aurangabad plant
Audi was planning to make these cars in India along with the Audi Q5, A6, A4, Q7
 "Luxury car maker Audi India starts production of Q3 SUV at Aurangabad plant")
El Nino unlikely to dampen tractor industry volumes in a big way
Likely El Niño may water down sentiment but industry does not see huge downside in sales in FY24
 "El Nino unlikely to dampen tractor industry volumes in a big way")
Indo-French team designing novel molecule to slay Covid-19 infection
Covid-19 is a complex disease with short-term as well as long-term respiratory, inflammatory and neurological symptoms that are triggered by the infection by Sars-CoV-2 virus
 "Indo-French team designing novel molecule to slay Covid-19 infection")
Mahindra and Mahindra gears up for EV play, niche e-farm products
M&M aims to make 200,000 EVs a year around 2027
 "Mahindra and Mahindra gears up for EV play, niche e-farm products")
After a slow start, PLI scheme may switch on the afterburners in FY24
Rs 8,083 cr is expected to be disbursed this fiscal
 "After a slow start, PLI scheme may switch on the afterburners in FY24")
Import of key Chinese medical devices rises up to 152% till Dec FY23
Overall imports decline 8% in first nine months of FY23
 "Import of key Chinese medical devices rises up to 152% till Dec FY23")
Pharma firm Ipca Labs' plant gets 3 observations from US drugs regulator
The observations were followed by the USFDA inspection at the site from April 18 to April 26
 "Pharma firm Ipca Labs' plant gets 3 observations from US drugs regulator")
Govt approves National Medical Devices Policy 2023, eyes 12% market share
Mansukh Mandaviya, Union health minister, said that the policy has been designed keeping in mind the need to have a holistic policy framework and will accelerate the growth of this sector
 "Govt approves National Medical Devices Policy 2023, eyes 12% market share")
Abbott recalls a batch of thyroid disorder drug for labelling error
Thyronorm has no quality issue, mislabeled batch was invoiced in Madhya Pradesh and Telangana: Company
 "Abbott recalls a batch of thyroid disorder drug for labelling error")
Looking for long-term partner for EV biz: M&M exec director & CEO Jejurikar
"We do not need any funds; we are well-covered at the moment"
 "Looking for long-term partner for EV biz: M&M exec director & CEO Jejurikar")
Bajaj Auto Q4 results: Revenue up 12%; PAT dips 2% to Rs 1,433 crore
'Export demand sluggishness may have bottomed out'
 "Bajaj Auto Q4 results: Revenue up 12%; PAT dips 2% to Rs 1,433 crore")
Serum Institute of India doubles Biocon investment to $300 million
The earlier investment by SILS in BBL was at a valuation of $4.9 billion, and the fresh $150-million investment pushes it up at $6 billion
 "Serum Institute of India doubles Biocon investment to $300 million")
GSK to bring Herpes Zoster vaccine Shingrix at one-third of US price: MD
Shingrix is for the prevention of shingles or what is also known as herpes zoster and also post-herpetic neuralgia in people aged 50 and above, says GSK Pharmaceuticals MD Bhushan Akshikar
 "GSK to bring Herpes Zoster vaccine Shingrix at one-third of US price: MD")
Paediatricians bat for Covid-19 vaccine for children as cases rise
Doctors say they are seeing an increase in children with Covid infection
 "Paediatricians bat for Covid-19 vaccine for children as cases rise")